Patient Portal

Information About Glaucoma

AGS Glaucoma Fellowship Requirements

The AGS Glaucoma Fellowship Requirements proposed by the AGS Education and Communication Committee and approved by the AGS Board of Directors  12.04.15.

View Program Requirements »


Know the New Glaucoma Staging Codes

Glaucoma Codes That Indicate Disease Severity

An EyeNet article by Ronald L. Fellman, MD, OCS, Cynthia G. Mattox, MD, Kim M. Ross, OCS, CPC, Academy Coding Specialist, and Sue Vicchrilli, COT, OCS, Academy Coding Executive


U.S. Preventative Services Task Force - Screening for Glaucoma: Draft Recommendation Statement

The American Academy of Ophthalmology and the American Glaucoma Society prepared joint comments on the U.S. Preventative Services Task Force. If you have questions, or if you need further information about this review, or any of the literature or evidence discussed, please contact Flora Lum, MD.


AHRQ Effective Health Care Programs

Comments on Screening and Treatment for Glaucoma

Joint comments of the American Academy of Ophthalmology and the American Glaucoma Society on two recent AHRQ Effective Health Care Program reviews on the screening and treatment for glaucoma.

MedPAC on Drug Adherence

The American Academy of Ophthalmology and the American Glaucoma Society strongly support MedPAC's continued research into the effects of patient adherence with Part D covered drugs and the impact on Medicare Part A and Part B spending. 

Learn More

AGS/AAO Comments to the FDA on Generics

The AGS and AAO recently became aware of proposed revisions to current standards and procedures for ensuring bioequivalence of ophthalmic emulsions, suspensions and ointments.

Our societies have concerns regarding the safety and rationale of the proposed changes outlined in the Federal Register Notice and the risks that might be encountered by patients under our care if these procedures were to be enacted.

Learn More

Compounding Pharmacies

The AAO has established a new task force to educate regulators, and monitor federal and state rules and legislation regarding Compounding Pharmacies. Sam Solish is the AGS representative on this task force. A letter was sent to all State Pharmacy boards, discussions have been held with the FDA, and recent meetings with Congress have occurred involving new regulations for Compounding Pharmacies.

View Message